National Vision initiated with a Buy at Roth Capital

Roth Capital analyst Matt Koranda initiated coverage of National Vision (EYE) with a Buy rating and $36 price target The firm says new management is driving a successful transformation with new pricing and a focus on attractive managed care customers. This should accelerate National Vision’s core America’s Best and Eyeglass World brands, and drive comp growth, the analyst tells investors in a research note.